"Access to essential gender-affirming care for minors is increasingly becoming a casualty of political pressure, even in states with protective laws, as healthcare providers navigate federal funding threats and a volatile legal environment."
The decision by Baystate Health to cease providing gender-affirming medications to minors, despite Massachusetts’s supportive legal framework, highlights a growing trend of healthcare institutions curtailing services under federal pressure. This move, which blindsided families like Bug’s, underscores the precarious position of transgender youth and their families as they seek vital medical support amidst an evolving and often hostile political climate. The ripple effects extend beyond individual patient care, impacting families who have strategically relocated for more inclusive environments and raising broader concerns about the future of LGBTQ+ healthcare access nationwide.
In late 2024, a sixth-grader known to his family as Bug, who was assigned female at birth, came home with a profound announcement: he was a boy and would be using he/him pronouns. His mother, identified only as J due to fears of harassment, responded with immediate support, asking, "What do you need to be supported?" Bug’s request for healthcare marked a pivotal moment, one J had anticipated since their family’s relocation from Texas to Massachusetts earlier that year. The move was a calculated decision, driven by a desire for more liberal and inclusive political and social policies. While J felt confident they could find the necessary medical expertise in Massachusetts, she soon discovered that access to gender-affirming treatment could be jeopardized, even in a state with strong legal protections.
This situation reflects a broader national trend. Across the United States, in both liberal and conservative states, individual hospitals have begun to withdraw gender-affirming care for minors. This pattern emerged in the early months of the Trump administration, which had explicitly targeted transgender healthcare, threatening to withhold federal funding and initiating investigations into potential fraud or wrongful claims. Reports indicate that at least 20 hospitals made such decisions within the initial phase of these threats, and the trend of service reduction has continued since. These actions often occur independently of state laws, driven by institutional fears of financial repercussions rather than direct legislative mandates.
Bug and his younger sister were born in Austin, Texas. However, J and her husband grew increasingly concerned about the state’s political trajectory. Texas had enacted legislation outlawing abortion, dismantled diversity, equity, and inclusion (DEI) programs, and enacted laws that restricted medical and civil rights for LGBTQ+ individuals. The parents worried that the support services crucial for their children, both of whom have autism, might be compromised. J described this anxiety as akin to "the frog in the boiling water," fearing a gradual erosion of rights and support that might go unnoticed until it was too late. This profound concern for their children’s well-being and future prompted the family’s decision to leave Texas.
Upon Bug’s coming out as transgender, J felt a measure of relief, knowing they had relocated to a state that not only offered a legal "shield" to protect providers offering gender-affirming care but also mandated that commercial insurance, like the plan Bug’s family held, cover such treatments. Massachusetts is among 24 states with such mandates. Following Bug’s gender identity declaration, J’s research led her to Baystate Health, the largest hospital system in their region, based in Springfield, Massachusetts. There, the family embarked on the months-long process of preparing Bug to begin hormone therapy.
Bug, an artistic 14-year-old with a passion for horses, cats, and filmmaking, was too old for puberty blockers. However, he was enthusiastically anticipating the commencement of testosterone therapy, which he understood would lead to a deepening of his voice, the growth of facial hair, and an increase in muscle mass. "Every part of it sounds fun," he expressed, looking forward to these physical changes as affirmations of his identity.
However, in February of the current year, just two weeks before Bug was scheduled to begin testosterone, Baystate Health announced it would no longer provide gender-affirming medications to minors, shifting to offering only counseling services. The letter sent to affected families did not provide a specific reason for the abrupt change.
Heather Duggan, a spokesperson for Baystate Health, issued a statement explaining that the decision to discontinue treatment for minors was a direct response to the Trump administration’s actions. The statement indicated that Baystate could potentially lose "hundreds of millions of dollars in government reimbursement" due to the administration’s plans. It further noted that "nearly 70 percent of Baystate Health’s patients rely on Medicaid and Medicare for coverage," highlighting the significant financial vulnerability of the institution to federal funding changes.
For Bug, the reality was stark: the medical care he had eagerly awaited was about to be withdrawn. "I felt frustrated that they would do that," he stated. He articulated the disappointment felt by many young people who, like him, were seeking gender-affirming healthcare, only to face setbacks and emotional distress. "I bet there’s tons and tons of kids who are like: ‘OK, I’m going for trans-affirming healthcare. Yay!’ And then, like, tons and tons of kids were disappointed and sad and frustrated," he shared.
J described the situation as feeling like "the floor had fallen out from under them." She admitted to a sense of naivety, stating, "Maybe this is naive, but I didn’t think that would happen in Massachusetts." Baystate Health is among several providers that have opted to cease offering puberty blockers and hormones while the legal challenges surrounding these treatments continue.
This spring, the legal landscape saw significant developments. Massachusetts joined a lawsuit challenging the federal government’s threats to withhold funding from providers offering gender-affirming care to minors. A federal judge ruled that the Department of Health and Human Services’ actions were unlawful. In June, another federal judge permitted 16 states, including Massachusetts, to proceed with a separate lawsuit against the administration concerning its efforts to criminalize gender-affirming care. Despite these legal victories for advocates of gender-affirming care, healthcare providers like Baystate Health continue to make their own decisions regarding service provision.
The American Academy of Pediatrics, while declining an interview, has previously stated that decisions about gender-affirming care should be made by young patients and their families in consultation with their doctors, emphasizing that such care should be "delivered with compassion, and offered without political interference."
One mother, identified as L, shared her experience with a former Baystate patient. Before her daughter came out as a transgender girl, she had struggled with severe depression and suicidal ideation. L reported that after Baystate doctors prescribed puberty blockers and estrogen, her daughter’s mood and academic performance improved significantly. The news of Baystate ending medical treatment left L "furious." She and other parents subsequently filed civil rights complaints with the Massachusetts attorney general’s office, which did not respond to a request for comment.
L expressed the profound emotional impact of such decisions, stating, "There’s a sense of, ‘How could you?’ And there’s also the awareness of the impact just pulling care could have on a youth—from a physical health perspective but also from a mental health perspective."
Both L and J managed to find alternative care for their children. L’s family transitioned to having their primary care physician manage hormone prescriptions. Bug’s family was referred to Transhealth, a private specialty clinic in Northampton, Massachusetts. Transhealth reported that it has since taken on approximately 50 former Baystate patients.
Jo Erwin, CEO of Transhealth, stated that the clinic had been staffing up in anticipation of such developments across the state. Erwin explained that Transhealth is better positioned to withstand funding threats due to significant private donations, which reduces its dependence on Medicaid and Medicare compared to larger hospital systems. However, Erwin acknowledged that this doesn’t entirely alleviate concerns within the broader LGBTQ+ community, including transgender adults. "When you see something like that go down, people get scared that it’s ultimately going to happen to everyone," Erwin commented.
The legal battles and political pressures surrounding gender-affirming care are playing out nationwide. In May, Colorado’s Supreme Court ordered a children’s hospital in that state to resume medical treatments for transgender youths. Conversely, in Texas, a court settlement compelled a children’s hospital to establish the nation’s first "detransition clinic." The Trump administration has continued its efforts to pressure providers, including by seeking the medical records of transgender minors.
After his initial setback at Baystate, Bug was able to begin testosterone therapy at the new clinic in the spring. J reported that the treatment is progressing smoothly, and Bug has successfully learned to administer his own injections. Nevertheless, J remains apprehensive about potential future federal interventions that could disrupt his care. She sometimes questions the family’s move from Texas, wondering if relocating to Canada might have offered a more secure environment. The ongoing uncertainty highlights the vulnerability of transgender youth and the critical need for stable, accessible gender-affirming care, free from political interference.
